Skip directly to content




April 2015

On Targets and Timelines
With growing recognition that science and discovery have forged the tools necessary to effectively diagnose, treat, and, indeed, eliminate three of the world’s most lethal infectious diseases—HIV/AIDS, tuberculosis, and hepatitis C—there is a need for greater mobilization and strengthened accountability among all stakeholders. Universal frameworks in which this can be achieved require time-bound targets: collaboratively developed, metrics-driven goals to optimize health outcomes among those living with the disease(s) and to minimize incidence among vulnerable individuals.
By Tim Horn

Ending the HIV Epidemic (ETE) in New York State
Not only is it the right thing to do for the health of New Yorkers, but a new analysis demonstrates that it is also cost-effective.
By Ginny Shubert, Housing Works; and Mark Harrington

Toward an Ambitious National HIV/AIDS Strategy
We won’t end HIV as an epidemic with anemic goals, delayed surveillance data, feeble support of state policies and resource needs, and an inadequate implementation science agenda.
By Kenyon Farrow

An HIV Cure and a Vaccine within the Next 15 Years?
Optimism is not without merit, but the science remains incredibly fragile.
By Richard Jefferys

C U L8ter: Hepatitis C Eradication
Hepatitis C is now curable. Now all we need is surveillance to monitor it, global funding to fight it, and targets set to address it.
By Tracy Swan

TB R&D’s Shift to the Left
As the Bill & Melinda Gates Foundation realigns its TB vaccine strategy to focus on early-stage candidate development, equitable access priorities must also be established before large-scale trials are conducted.
By Mike Frick